
Avanza Life Sciences Private Limited
About Avanza Life Sciences Private Limited
Data last updated:
Avanza Life Sciences Private Limited is a private limited company based in Kalamassery, Kerala, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 09 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51909KL2014PTC036856. Its GSTIN is 32AAMCA7348C1ZU (Kerala).
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹1.56 Cr. It is led by directors including Raju Paul and Cheruvalappil Akbar.
Its last annual general meeting (AGM) was held on 31 December 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Xxv/184B – 1 Kalarakkal Building Akg Road Edappally, Kalamassery, Kerala, India – 682024.
As per the financials filed for FY 2023, the company reported a revenue of ₹68.64 Lakh, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹64.83 Lakh (net margin -94.5%) and EBITDA of -₹61.3 Lakh (EBITDA margin -89.3%). Revenue has grown at a compounded annual rate (CAGR) of 267% over three years and 32% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Avanza Life Sciences Private Limited's registered office is in Kalamassery, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressXxv/184B – 1 Kalarakkal Building Akg Road Edappally, Kalamassery, Kerala, India – 682024
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Avanza Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avanza Life Sciences is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Avanza Life Sciences Private Limited, buy the company report.
Financials of Avanza Life Sciences Private Limited
FY 2023 filings availableAvanza Life Sciences Private Limited reported revenue of ₹68.64 Lakh (down 51% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 51% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 32%. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹61.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹64.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -89.3% | ||||
| Net Profit Margin | -94.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avanza Life Sciences Private Limited, buy the company report.
Board of directors of Avanza Life Sciences Private Limited
Avanza Life Sciences has 7 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohamed Anwar Also directs: Perfimed Services Private Limited | Additional Director | 01 Oct 2020 | 6 Years 1 Months | Current |
| Azghar Kondayan Ashraf Also directs: Perfimed Services Private Limited | Additional Director | 24 Aug 2020 | 6 Years 2 Months | Current |
| Raju Paul | Director | 09 Jul 2014 | 12 Years 4 Months | Current |
| Cheruvalappil Akbar Also directs: Perfimed Services Private Limited, NBD Healthcare Private Limited | Director | 09 Jul 2014 | 12 Years 4 Months | Current |
| Tarson Aloor Francis | Director | 01 May 2017 | 9 Years 6 Months | Current |
| Puthan Veetil Ajayakumar | Director | 01 May 2017 | 9 Years 6 Months | Current |
Auditor
Avanza Life Sciences Private Limited is audited by G VENUGOPAL KAMATH & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G VENUGOPAL KAMATH & CO | FY 2017 | 004674S |
Shareholding
The shareholding of Avanza Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Avanza Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Avanza Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avanza Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Avanza Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAMCA7348C1ZU | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Avanza Life Sciences Private Limited, buy the company report.
Recent activity
Avanza Life Sciences Private Limited has 11 board changes on record since 2014: 7 appointments and 4 cessations. The latest: Mohamed Anwar was appointed as Additional Director on 01 Oct 2020.
2 earlier events are in the company report.
Frequently asked questions
Avanza Life Sciences is an active private limited company based in Kalamassery, Kerala, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 09 July 2014 (12+ years old) and is registered under CIN U51909KL2014PTC036856.
Avanza Life Sciences has 7 current directors:
- Mohamed Anwar - Additional Director
- Azghar Kondayan Ashraf - Additional Director
- Raju Paul - Director
- Cheruvalappil Akbar - Director
- Tarson Aloor Francis - Director
- Puthan Veetil Ajayakumar - Director
- Vadakumbadan Bhaskaran - Director
The latest financial statements of Avanza Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 December 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Avanza Life Sciences is 32AAMCA7348C1ZU, registered in Kerala.
The CIN (Corporate Identification Number) of Avanza Life Sciences is U51909KL2014PTC036856. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avanza Life Sciences was incorporated on 09 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ernakulam.
Mohamed Anwar was appointed as Additional Director on 01 Oct 2020. Azghar Kondayan Ashraf was appointed as Additional Director on 24 Aug 2020. Mekkattukulam Dominic Varghese ceased to be Director on 15 Jan 2020. Avanza Life Sciences has 11 board changes on record in total.
The registered office of Avanza Life Sciences is at Xxv184B – 1 Kalarakkal Building Akg Road Edappally, Kalamassery, Kerala, India – 682024.
Avanza Life Sciences operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Avanza Life Sciences is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.

